PATENT CLAIM ANALYSIS

Application Number: 15950042
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-12
Patent Classification: ["424", "093730"]

Abstract:
The invention provides methods of increasing the efficacy of a T cell therapy in a patient in need thereof. The invention includes a method of conditioning a patient prior to a T cell therapy, wherein the conditioning involves administering a combination of cyclophosphamide and fludarabine.

Claim (Index 137):
The method of  claim 135 , wherein the dose of fludarabine is administered for three days.

Metadata:
- Claim Count in Document: 23.0
- Percentile: 91.0
- Lexical Diversity: 1.6
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15649369', '15167977', '14680860', '14996953', '14918451']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7801671851748151
- 35 USC 102 Novelty (BERT): 0.6436197261356525
- Combined Prediction Score: 0.7665124392708988
- Mean Citation Score: 486.130018
- Max Citation Score: 702.39386
- Similarity Product: 557.9946863457956

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test